Published in Metabolism on February 01, 2005
Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics. Arterioscler Thromb Vasc Biol (2015) 0.92
Impact of type 1 diabetes and body weight status on cardiovascular risk factors in adolescent children. J Clin Hypertens (Greenwich) (2010) 0.80
Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes. J Clin Lipidol (2012) 0.76
Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee. J Lipids (2017) 0.75
Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 0.75
Sex differences in HDL ApoC-III in American Indian youth. Biol Sex Differ (2012) 0.75
Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. J Diabetes Complications (2013) 0.75
Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension (2007) 4.20
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA (2008) 3.16
Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care (2006) 2.90
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J Hypertens (2003) 2.24
Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol (2003) 2.20
Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet (2011) 2.13
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J (2006) 2.08
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J Am Coll Cardiol (2002) 2.08
Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation (2002) 2.05
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol (2006) 2.00
Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study. J Hypertens (2010) 2.00
Interrelationships between the concentration and size of the largest high-density lipoprotein subfraction and apolipoprotein C-I in infants at birth and follow-up at 2-3 months of age and their parents. J Clin Lipidol (2012) 1.96
Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke (2005) 1.96
Short leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study. Diabetes (2013) 1.91
Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol (2008) 1.81
Variation in symptoms of sleep-disordered breathing with race and ethnicity: the Sleep Heart Health Study. Sleep (2003) 1.81
High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol (2009) 1.79
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens (2005) 1.79
Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study. Circulation (2007) 1.78
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke (2008) 1.67
Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study. Circulation (2007) 1.67
Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation (2008) 1.67
Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins. Am J Clin Nutr (2011) 1.62
Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J Hypertens (2011) 1.61
Linkage analysis of glomerular filtration rate in American Indians. Kidney Int (2008) 1.59
Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension (2006) 1.59
A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study. Hypertension (2006) 1.57
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol (2004) 1.48
Repolarization abnormality for prediction of all-cause and cardiovascular mortality in American Indians: the Strong Heart Study. J Cardiovasc Electrophysiol (2005) 1.47
Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes. Am J Clin Nutr (2007) 1.46
Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study. Circulation (2006) 1.46
Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care (2007) 1.42
Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care (2002) 1.37
Incidence of diabetes in American Indians of three geographic areas: the Strong Heart Study. Diabetes Care (2002) 1.37
Prevalence of diabetes and impaired fasting glucose in Chinese adults, China National Nutrition and Health Survey, 2002. Prev Chronic Dis (2010) 1.36
Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr (2006) 1.35
Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study. Hypertension (2005) 1.35
Heritability of left ventricular dimensions and mass in American Indians: The Strong Heart Study. J Hypertens (2004) 1.30
C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation (2005) 1.29
Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol (2012) 1.29
Changes in cardiovascular disease risk factors among American Indians. The Strong Heart Study. Ann Epidemiol (2002) 1.27
Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension (2009) 1.26
Tobacco use among American Indians in Oklahoma: an epidemiologic view. Public Health Rep (2005) 1.26
Heritability of carotid artery structure and function: the Strong Heart Family Study. Arterioscler Thromb Vasc Biol (2002) 1.20
The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab (2002) 1.20
Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol (2003) 1.20
Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology (2002) 1.17
Association of blood pressure with blood viscosity in american indians: the Strong Heart Study. Hypertension (2005) 1.17
Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens (2010) 1.16
Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study. Circulation (2004) 1.16
Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: the Strong Heart Study. Diabetes Care (2011) 1.15
Vascular biomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study. Hypertension (2011) 1.12
Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study. Diabetes Care (2004) 1.12
Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study. Diabetes Metab Res Rev (2010) 1.12
Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study. Diabetes Care (2011) 1.08
Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study. Am J Clin Nutr (2008) 1.08
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo. J Lipid Res (2009) 1.08
Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS). Am Heart J (2006) 1.08
Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care (2004) 1.07
Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes (2004) 1.07
The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study. Diabetes Care (2002) 1.06
Aging and the prevalence of cardiovascular disease risk factors in older American Indians: the Strong Heart Study. J Am Geriatr Soc (2007) 1.05
Principal component analysis of the T wave and prediction of cardiovascular mortality in American Indians: the Strong Heart Study. Circulation (2002) 1.04
Macronutrient intake and glycemic control in a population-based sample of American Indians with diabetes: the Strong Heart Study. Am J Clin Nutr (2007) 1.04
Left atrial systolic force and cardiovascular outcome. The Strong Heart Study. Am J Hypertens (2005) 1.03
Genetic influences on aortic root size in American Indians: the Strong Heart Study . Arterioscler Thromb Vasc Biol (2002) 1.01
Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family Study. Hum Mol Genet (2010) 1.00
Evidence for genetic factors underlying the insulin resistance syndrome in american indians. Obes Res (2003) 1.00
Metabonomic Evaluation of ZHENG Differentiation and Treatment by Fuzhenghuayu Tablet in Hepatitis-B-Caused Cirrhosis. Evid Based Complement Alternat Med (2012) 0.99
Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes. Diabetes Care (2006) 0.99
Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study). Am J Cardiol (2006) 0.98
Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes (2002) 0.98
Studies of the composition and structure of plasma lipoproteins. C- and N-terminal amino acids of the two nonidentical polypeptides of human plasma apolipoprotein A. FEBS Lett (1971) 0.98
Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study. Am Heart J (2003) 0.98
Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study. Diabetes Care (2002) 0.98
Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart Study. J Hypertens (2008) 0.97
Physical activity and incident diabetes in American Indians: the Strong Heart Study. Am J Epidemiol (2009) 0.97
Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis (2007) 0.96
The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study. Hum Genet (2010) 0.96
Applications of New Technologies and New Methods in ZHENG Differentiation. Evid Based Complement Alternat Med (2012) 0.95
Linkage study of fibrinogen levels: the Strong Heart Family Study. BMC Med Genet (2008) 0.94
An appraisal of echocardiography as an epidemiological tool. The Strong Heart Study. Ann Epidemiol (2003) 0.93
Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study. Am J Kidney Dis (2012) 0.92
Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase. Arterioscler Thromb Vasc Biol (2003) 0.92
Cardiac geometry and function in diabetic or prediabetic adolescents and young adults: the Strong Heart Study. Diabetes Care (2011) 0.92
Relationship between glycemic control and depression among American Indians in the Strong Heart Study. J Diabetes Complications (2009) 0.92
Genetic determination of acute phase reactant levels: the strong heart study. Hum Hered (2004) 0.91
Comparison of estimated glomerular filtration rates and albuminuria in predicting risk of coronary heart disease in a population with high prevalence of diabetes mellitus and renal disease. Am J Cardiol (2011) 0.91